First Time Loading...

Cryo-Cell International Inc
NASDAQ:CCEL

Watchlist Manager
Cryo-Cell International Inc Logo
Cryo-Cell International Inc
NASDAQ:CCEL
Watchlist
Price: 9.38 USD 2.07% Market Closed
Updated: May 16, 2024

Income Statement

Earnings Waterfall
Cryo-Cell International Inc

Revenue
31.4m USD
Cost of Revenue
-8.5m USD
Gross Profit
22.8m USD
Operating Expenses
-36m USD
Operating Income
-13.2m USD
Other Expenses
3.4m USD
Net Income
-9.7m USD

Income Statement
Cryo-Cell International Inc

Rotate your device to view
Income Statement
Currency: USD
Feb-2014 May-2014 Aug-2014 Nov-2014 Feb-2015 May-2015 Aug-2015 Nov-2015 Feb-2016 May-2016 Aug-2016 Nov-2016 Feb-2017 May-2017 Aug-2017 Nov-2017 Feb-2018 May-2018 Aug-2018 Nov-2018 Feb-2019 May-2019 Aug-2019 Nov-2019 Feb-2020 May-2020 Aug-2020 Nov-2020 Feb-2021 May-2021 Aug-2021 Nov-2021 Feb-2022 May-2022 Aug-2022 Nov-2022 Feb-2023 May-2023 Aug-2023 Nov-2023 Feb-2024
Revenue
Revenue
20
N/A
20
+0%
20
+1%
20
+1%
20
-2%
20
+1%
20
+3%
21
+4%
21
+1%
22
+4%
23
+4%
23
+0%
24
+3%
24
+2%
25
+2%
25
+2%
26
+2%
26
+1%
27
+4%
29
+8%
30
+4%
32
+5%
32
+1%
32
-2%
32
+0%
32
-1%
32
0%
31
-1%
30
-2%
30
-2%
29
-2%
29
-1%
29
+1%
30
+1%
30
+1%
30
+2%
31
+2%
31
+0%
31
+1%
31
+0%
31
+0%
Gross Profit
Cost of Revenue
(5)
(5)
(6)
(6)
(6)
(5)
(5)
(6)
(6)
(6)
(6)
(6)
(6)
(6)
(7)
(7)
(7)
(7)
(8)
(9)
(9)
(10)
(10)
(10)
(10)
(10)
(10)
(10)
(9)
(9)
(9)
(9)
(9)
(9)
(9)
(9)
(9)
(9)
(9)
(8)
(9)
Gross Profit
14
N/A
14
-1%
14
0%
14
+2%
14
-3%
14
+2%
15
+3%
15
+4%
16
+2%
16
+4%
17
+5%
17
+1%
18
+3%
18
+2%
18
+1%
19
+2%
19
+2%
19
+1%
20
+2%
21
+5%
21
+2%
22
+4%
22
+1%
22
-1%
22
+0%
22
0%
22
+1%
21
-2%
21
-1%
21
-2%
20
-3%
20
-1%
20
+2%
21
+2%
21
+1%
22
+3%
22
+3%
22
+1%
23
+2%
23
+1%
23
0%
Operating Income
Operating Expenses
(12)
(12)
(12)
(12)
(12)
(12)
(12)
(13)
(14)
(14)
(15)
(15)
(18)
(14)
(14)
(14)
(14)
(14)
(15)
(15)
(16)
(16)
(15)
(14)
(18)
(15)
(15)
(13)
(15)
(14)
(12)
(15)
(16)
(17)
(18)
(18)
(18)
(18)
(18)
(18)
(36)
Selling, General & Administrative
(12)
(12)
(12)
(12)
(12)
(12)
(12)
(12)
(13)
(13)
(15)
(15)
(14)
(14)
(14)
(13)
(14)
(14)
(15)
(16)
(16)
(16)
(15)
(15)
(15)
(15)
(15)
(14)
(14)
(13)
(14)
(15)
(15)
(15)
(15)
(16)
(16)
(16)
(16)
(17)
(18)
Research & Development
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(2)
Depreciation & Amortization
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
Other Operating Expenses
0
0
0
0
0
0
0
0
0
0
0
0
(4)
0
0
0
0
0
0
0
0
0
0
1
(2)
(0)
0
2
(1)
(0)
2
1
1
1
(0)
(0)
(0)
(0)
(0)
1
(16)
Operating Income
2
N/A
2
+26%
2
-6%
2
-12%
2
-10%
2
+2%
3
+45%
3
+9%
2
-39%
3
+54%
2
-16%
2
+5%
(1)
N/A
4
N/A
4
+17%
5
+16%
5
-3%
5
-1%
4
-11%
5
+20%
5
-3%
6
+13%
7
+20%
7
+9%
4
-42%
7
+56%
7
+7%
9
+24%
7
-26%
7
+4%
8
+22%
5
-37%
4
-18%
3
-19%
3
-19%
4
+43%
4
+5%
4
-4%
4
+5%
5
+6%
(13)
N/A
Pre-Tax Income
Interest Income Expense
(2)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(2)
(0)
(2)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
Non-Reccuring Items
0
(0)
(0)
(0)
0
0
0
(1)
0
(0)
(5)
(4)
0
(4)
(0)
0
0
0
0
0
0
(2)
(2)
(2)
0
0
(1)
(2)
0
0
(1)
(1)
0
0
0
0
0
0
0
(17)
0
Gain/Loss on Disposition of Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
0
0
0
0
0
0
Total Other Income
0
0
0
0
0
0
(0)
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Pre-Tax Income
0
N/A
1
+126%
1
+3%
1
-16%
1
-20%
1
N/A
1
+119%
1
-20%
1
-45%
1
+115%
(3)
N/A
(2)
+25%
(2)
+37%
(2)
-1%
3
N/A
4
+17%
4
-3%
4
+1%
3
-17%
4
+23%
3
-8%
3
-23%
4
+41%
3
-7%
4
+16%
5
+31%
4
-13%
5
+12%
5
+0%
5
+6%
6
+6%
3
-54%
3
+8%
2
-26%
1
-30%
3
+128%
3
+2%
3
-16%
3
+15%
(13)
N/A
(14)
-3%
Net Income
Tax Provision
(0)
(0)
(0)
(0)
(0)
(0)
7
7
7
7
1
1
1
1
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(0)
(0)
(1)
(1)
(1)
(1)
4
4
Income from Continuing Operations
0
1
1
1
0
0
8
8
8
8
(2)
(1)
(1)
(1)
2
2
2
2
2
2
2
2
2
2
3
4
3
4
4
4
4
2
2
2
1
3
3
2
3
(10)
(10)
Net Income (Common)
0
N/A
1
+256%
1
+8%
1
-20%
0
-19%
0
-2%
8
+1 725%
8
+1%
8
-5%
8
+6%
(2)
N/A
(1)
+44%
(1)
+47%
(1)
-20%
2
N/A
2
-6%
(1)
N/A
(1)
+6%
(1)
-61%
(1)
+20%
2
N/A
1
-25%
2
+59%
2
-2%
3
+18%
4
+33%
3
-9%
4
+11%
4
+0%
4
+6%
4
+2%
2
-47%
2
+7%
2
-24%
1
-23%
3
+114%
3
-2%
2
-15%
3
+9%
(10)
N/A
(10)
-2%
EPS (Diluted)
0.02
N/A
0.06
+200%
0.06
N/A
0.05
-17%
0.04
-20%
0.04
N/A
0.82
+1 950%
0.83
+1%
0.85
+2%
0.86
+1%
-0.31
N/A
-0.16
+48%
-0.09
+44%
-0.1
-11%
0.33
N/A
0.3
-9%
-0.09
N/A
-0.08
+11%
-0.12
-50%
-0.11
+8%
0.23
N/A
0.17
-26%
0.27
+59%
0.27
N/A
0.32
+19%
0.44
+38%
0.4
-9%
0.45
+13%
0.45
N/A
0.47
+4%
0.45
-4%
0.25
-44%
0.26
+4%
0.19
-27%
0.15
-21%
0.33
+120%
0.32
-3%
0.27
-16%
0.3
+11%
-1.14
N/A
-1.18
-4%

See Also

Discover More